Showing results (701-710 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Synergistic anti-tumor effect of mini-cells prepared from Salmonella typhimurium with mitomycin C in EL4-bearing miceS Kurashige, K Kodama, T YoshidaCancer Immunology, Immunotherapy : CII|January 1, 1995
CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashionR Dadmarz, M K Sgagias, S A Rosenberg, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1995
Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in miceT Jimbo, T Akimoto, A TohgoCancer Immunology, Immunotherapy : CII|January 1, 1995
Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 geneY Iwanuma, K Kato, H Yagita, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1995
Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamineD Risin, E S Kleinerman, Y Umezu, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1982
Mitogen responsiveness and inhibitory activity of mesenteric lymph node cells. Conditioned medium containing T cell growth factor reverses suppressor functionB M Vose, R Ferguson, M MooreCancer Immunology, Immunotherapy : CII|March 1, 1995
Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivoM B Moreno, J A Titus, M S Cole, et al.Cancer Immunology, Immunotherapy : CII|January 12, 2008
Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancerDuane H Hamilton, Peter A BretscherCancer Immunology, Immunotherapy : CII|February 28, 2008
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cellsFrank Grünebach, Stefanie Erndt, Maik Häntschel, et al.Cancer Immunology, Immunotherapy : CII|March 5, 2008
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapyKarl-Johan Malmberg, Yenan T Bryceson, Mattias Carlsten, et al.Pageof 650